Prospective Area Registry of ARNI for Congestive heart failUre in Tokyo East

Prospective Area Registry of ARNI for Congestive heart failUre in Tokyo East - Prospective Area Registry of ARNI for Congestive heart failUre in Tokyo East

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044603

Enrollment

200

Registered

2021-06-20

Start date

2021-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congestive heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Congestive heart failure patients who start taking sacubitril/valsartan

Exclusion criteria

Exclusion criteria: 1) Contraindication for sacubitril/valsartan 2) systolic blood pressure <95 mmHg 3) eGFR<30 mL/min/1.73m2 4) serum K>5.5 mEq/L 5) BNP<100 pg/mL or NT-pro BNP<300 pg/mL 6) Patients with expected survival of 12 months or less 7) Patients that the doctor deems inappropriate for participation in the study

Design outcomes

Primary

Measure	Time frame
Left ventricular ejection fraction	—

Secondary

Measure	Time frame
1) NT-pro BNP 2) ANP 3) BUN/Cr/eGFR 4) Vital signs 5) NYHA classification 6) Cardio Thoracic Ratio 7) Transthoracic echocardiography data 8) All cause death, cardiovascular death, all cause hospitalization, hospitalization for heart failure	—

Countries

Japan

Contacts

Public ContactTAKURO ABE

Nishiarai heart center hospital Cardiology

abetakuro1009@gmail.com03-5838-0730

Outcome results